<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>D-FT.CE.111.FB.2.CAP3G</udiDi>
    <basicUdiDi>B-FT.CE.111.FB.2.CAP3G</basicUdiDi>
    <tradeName>Caregyn vaginal ovules</tradeName>
    <deviceName>Caregyn vaginal ovules (serbia)</deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>FT.CE.111.FB.2.CAP</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:22:31.772Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FT.CE.111.FB.15P</udiDi>
    <basicUdiDi>B-FT.CE.111.FB.15P</basicUdiDi>
    <tradeName>Cliagin</tradeName>
    <deviceName>Cliagin</deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FT.CE.111</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:22:27.744Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FT.CE.111.FB.135N</udiDi>
    <basicUdiDi>B-FT.CE.111.FB.135N</basicUdiDi>
    <tradeName>Gyn 10 ovuli</tradeName>
    <deviceName>Gyn 10 ovuli</deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FT.CE.111.FB.13</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:22:26.947Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FT.CE.111.FB.125L</udiDi>
    <basicUdiDi>B-FT.CE.111.FB.125L</basicUdiDi>
    <tradeName>Gynacid ovules</tradeName>
    <deviceName>Gynacid ovules</deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FT.CE.111.FB.12</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:22:26.149Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FT.CE.111.FA.45Q</udiDi>
    <basicUdiDi>B-FT.CE.111.FA.45Q</basicUdiDi>
    <tradeName>Lotamile Boric +</tradeName>
    <deviceName>Lotamile Boric +</deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FT.CE.111</reference>
    <placedOnMarketCountry>Lithuania</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:22:25.345Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FT.CE.111.FA.155K</udiDi>
    <basicUdiDi>B-FT.CE.111.FA.155K</basicUdiDi>
    <tradeName>Mivagyn Bor</tradeName>
    <deviceName>Mivagyn Bor</deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FT.CE.111</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:22:21.342Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FT.CE.109U5</udiDi>
    <basicUdiDi>B-FT.CE.109U5</basicUdiDi>
    <tradeName>XY AQUAGEL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FT.CE.109</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:22:20.543Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FT.CE.109.9CN</udiDi>
    <basicUdiDi>B-FT.CE.109.9CN</basicUdiDi>
    <tradeName>SEMINA AQUAGEL</tradeName>
    <deviceName>SEMINA AQUAGEL</deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FT.CE.109.9</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:22:19.735Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FT.CE.109.8CL</udiDi>
    <basicUdiDi>B-FT.CE.109.8CL</basicUdiDi>
    <tradeName>TEN fertil ZEL</tradeName>
    <deviceName>TEN fertil ZEL</deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FT.CE.109.8</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:22:18.937Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FT.CE.109.7CJ</udiDi>
    <basicUdiDi>B-FT.CE.109.7CJ</basicUdiDi>
    <tradeName>VAGYFERT</tradeName>
    <deviceName>VAGYFERT</deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FT.CE.109.7</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:22:16.050Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FT.CE.109.6CG</udiDi>
    <basicUdiDi>B-FT.CE.109.6CG</basicUdiDi>
    <tradeName>LUBRIFERT</tradeName>
    <deviceName>LUBRIFERT</deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FT.CE.109.6</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:22:15.742Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FT.CE.109.5CE</udiDi>
    <basicUdiDi>B-FT.CE.109.5CE</basicUdiDi>
    <tradeName>ROSELIT</tradeName>
    <deviceName>ROSELIT</deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FT.CE.109.5</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:22:13.334Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FT.CE.109.4CC</udiDi>
    <basicUdiDi>B-FT.CE.109.4CC</basicUdiDi>
    <tradeName>YARILO MOTILITY</tradeName>
    <deviceName>YARILO MOTILITY</deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FT.CE.109.4</reference>
    <placedOnMarketCountry>Czechia</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:22:12.535Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FT.CE.109.1453</udiDi>
    <basicUdiDi>B-FT.CE.109.1453</basicUdiDi>
    <tradeName>PREGNAID gel</tradeName>
    <deviceName>PREGNAID gel</deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FT.CE.109.14</reference>
    <placedOnMarketCountry>Finland</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:22:08.535Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FT.CE.109.134Z</udiDi>
    <basicUdiDi>B-FT.CE.109.134Z</basicUdiDi>
    <tradeName>D-FT.CE.109.134Z</tradeName>
    <deviceName>XY FERTIMAX GEL</deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>FT.CE.109.13</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:22:07.745Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FT.CE.109.10A6K</udiDi>
    <basicUdiDi>B-FT.CE.109.10A6K</basicUdiDi>
    <tradeName>FERTY plus</tradeName>
    <deviceName>FERTY plus</deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FT.CE.109.10A</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:22:07.156Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FR-MF-0000158804T</udiDi>
    <basicUdiDi>B-FR-MF-0000158804T</basicUdiDi>
    <tradeName>GYNOPHILUS</tradeName>
    <deviceName>Gynophilus, vaginal capsule</deviceName>
    <manufacturerName>BIOSE INDUSTRIE</manufacturerName>
    <manufacturerSrn>FR-MF-000015880</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>F1-19-01</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-13T18:39:33.468Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FR-MF-000015880-00135</udiDi>
    <basicUdiDi>B-FR-MF-000015880-00135</basicUdiDi>
    <tradeName>Gynophilus Restore</tradeName>
    <deviceName>Gynophilus LP Vaginal Tablet</deviceName>
    <manufacturerName>BIOSE INDUSTRIE</manufacturerName>
    <manufacturerSrn>FR-MF-000015880</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>F1-18-01</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-13T18:39:31.867Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-EVAINTMD30013V</udiDi>
    <basicUdiDi>B-EVAINTMD30013V</basicUdiDi>
    <tradeName>EVA INTIMA BIOLACT OVULES</tradeName>
    <deviceName>EVA INTIMA BIOLACT OVULES</deviceName>
    <manufacturerName>IOULIA AND IRENE TSETI PHARMACEUTICAL LABORATORIES S.A.</manufacturerName>
    <manufacturerSrn>GR-MF-000032958</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>EVA INTIMA BIOLACT OVULES</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-07-13T18:08:54.252Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-EVAINTMD290153</udiDi>
    <basicUdiDi>B-EVAINTMD290153</basicUdiDi>
    <tradeName>EVA INTIMA BIOLACT DOUCHE</tradeName>
    <deviceName>EVA INTIMA BIOLACT DOUCHE</deviceName>
    <manufacturerName>IOULIA AND IRENE TSETI PHARMACEUTICAL LABORATORIES S.A.</manufacturerName>
    <manufacturerSrn>GR-MF-000032958</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>EVA INTIMA BIOLACT DOUCHE</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-07-13T18:08:52.458Z</lastUpdated>
  </row>
</eudamedExport>